*Journal of Hepatocellular Carcinoma* (JHC) is a peer-reviewed, comprehensive, multidisciplinary, international journal for publication of original, review, editorial, and commentary articles in addition to expert consensus statements and reports in all clinical and research aspects of hepatocellular carcinoma (HCC). JHC is indexed in PubMed and PubMed Central (*J Hepatocell Carcinoma*), and in the Emerging Sources Citation Index.

The overarching objective of the JHC is to provide a better understanding of risk factors, pathogenesis, and clinical management of HCC and to advance collaboration and dialogue between researchers and clinicians in academic, private practice, and industry settings. Since its inception, papers submitted to JHC have represented a wide range of articles, including clinical trials,[@b1-jhc-5-051] review articles in both research and clinical topics,[@b2-jhc-5-051]--[@b4-jhc-5-051] editorials, commentaries, case series, and an important expert consensus statement on liver imaging.[@b5-jhc-5-051]

Our journal strategy going forward will be encouraging and incentivizing publications related to multidisciplinary research and clinical topics that could potentially have a significant impact on HCC management. Specifically, of high interest are articles related to understanding and managing this peculiar cancer, which usually involves a two-disease state: HCC and underlying chronic liver disease. Additionally, to date, significant progress has been achieved in the area of comprehensive multidisciplinary and individualized HCC screening and treatment algorithms. However, certain advanced modalities for HCC screening and treatment are relatively expensive, especially in certain developing countries, where local resources and health care budget are limited.

Therefore, in response to a call from the HCC scientific community, we are launching a new era in JHC that will address the global differences in HCC risk factors and management strategies. JHC is launching a Call for Papers: we are seeking to publish multidisciplinary clinical and translational studies, in addition to cost-effective screening and treatment strategies and consensus statements including those which take into account available local resources. Notably, the rapidly evolving field of immunotherapy as a treatment for HCC has shown substantial promise.[@b6-jhc-5-051] Therefore, of major interest to our journal and its readers are basic and clinical research reports in the field of HCC immunotherapy. The full Call for Papers can be found here: <https://www.dovepress.com/journal-of-hepatocellular-carcinoma-archive148>.

Finally, we are proud to welcome our newly expanded Editorial Board (please see Supplementary material for the complete list), which now includes a larger global representation by established HCC expert clinicians and academicians from all continents. On behalf of JHC Editorial Board, we herein invite you to submit your manuscripts, suggestions, and interesting ideas to improve our journal performance and truly represent global HCC clinical and research topics to improve the dismal outcome of our HCC patients.
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